Efficient Treatment Strategies for Neurological and Kidney Diseases using the Power of Artificial Intelligence and Systems Biology.
We study the interactions between the host and oral/gut microbiome through the integration of multi-omics data and employ this information to identify effective drug targets and prognostic biomarkers. We also perform drug repositioning applications to use the existing drugs for treatment of such diseases and identify their potential side effects.
Our Current Programs
Our Current Platforms
Latest News
View All NewsNovember 11, 2021
Bash Biotech Releases a report about the GutMicroNet: an interactive platform for gut microbiome interaction exploration
June 11, 2021
Bash Biotech Releases a report about the stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning
April 13, 2021
Bash Biotech Releases a report about the iNetModels 2.0: an interactive visualization and database of multi-omics data
April 1, 2021
Bash Biotech Releases a report about the Global and temporal state of the human gut microbiome in health and disease
January 14, 2021
Bash Biotech Releases Preliminary Report of iNetModels 2.0: An Interactive Visualization and Database of Multi-omics Data
July 21, 2020
Bash Biotech raises $1M In Seed Funding To Bring The Power of Artificial Intelligence Into Biopharmaceutical Industry